John Davelaar

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy”.

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

Gastroenterology(2022)10.1053/j.gastro.2022.06.027

N/A

0DataRank · unranked

76 citations

Jianxin Wang, John Davelaar, Andrew Baker, Keyu Li, Nan Niu +17 more

Trial in progress: A randomized phase II study of pembrolizumab with or without defactinib, a focal adhesion kinase inhibitor, following chemotherapy as a neoadjuvant and adjuvant treatment for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4192

N/A

0DataRank · unranked

6 citations

Zachariah Brown, Sheila Linden, Christina Rodriguez, Omer H. Elmadbouh, Jonathan A. Pachter +9 more

Preliminary translational immune and stromal correlates in a randomized phase II trial of pembrolizumab with or without defactinib for resectable pancreatic ductal adenocarcinoma (PDAC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4024

N/A

0DataRank · unranked

5 citations

John Davelaar, Jessica Gai, Zachariah Brown, Abrahm Levi, Sheila Linden +15 more

Neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC) with germline DNA damage repair (DDR) mutations: A dual institution retrospective study.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.4164

N/A

0DataRank · unranked

1 citations

Marco Ventin, Giulia Cattaneo, Arya Shahrzad, Anser Abbas, Brent K. Larson +13 more

Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database

The Oncologist(2025)10.1093/oncolo/oyaf007

N/A

0DataRank · unranked

7 citations

Edik M. Blais, John Davelaar, Matthew Ebia, Angela Minasyan, Nima Nikravesh +13 more

Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care

HPB(2025)10.1016/j.hpb.2025.07.012

N/A

0DataRank · unranked

0 citations

Anser Abbas, Abrahm Levi, John Davelaar, Elissa Rosenberg, Katelyn M. Atkins +18 more